Business - News | MDDI Online

Medtech in a Minute: Philips Regulatory Win, Eko’s Telemedicine Play, and More

Pressed for time? Here's the medtech news you need most, in one minute or less.

The New Normal of Workplace Safety

What can employees expect when they return to workplaces?

Will Medtronic Emerge from the Pandemic Even Stronger?

COVID-19 took a heavy toll on Medtronic's most recent fiscal quarter, but given the company's strong pipeline and balance sheet, the company could emerge from the pandemic stronger than ever.

3 Roche Companies Hope to Make Clinical Trials More Efficient

Flatiron Health, Foundation Medicine, and Genentech have launched the Prospective Clinico-Genomic (PCG) feasibility study. The trial will pilot the use of a technology-enabled prospective data collection platform to facilitate, streamline, and simplify the execution of clinical trials for patients living with advanced lung cancer.

Edwards Makes Gains in Tricuspid Regurgitation Repair with CE Mark

The Irvine, CA-based company said its Pascal System has not yet been approved in the U.S.

Microsoft and UnitedHealth Launch App that Screens for COVID-19 Symptoms

The collaboration will help support return-to-workplace planning for employers and employees.

Medtech in a Minute: COVID-19 Fraud, a Virtual AFib Trial, and More

Pressed for time? Here's the medtech news you need most, in one minute or less. Now available as a podcast.

Grail Raises $390M in Latest Financing Round

The Menlo Park, CA-based company has raised about $1.9 billion across four financing rounds.

Pulmonx Delays IPO and Reels in $66M Financing

The Redwood City, CA-based company was all set to go public. However, the negative impact of COVID-19 on the market caused Pulmonx to switch gears. Now the firm has raised $66 million to push the commercialization of its minimally invasive treatment for severe emphysema.

High Demand Caused by COVID-19 Helps Baxter Beat 1Q20 Expectations

The Deerfield, IL-based company saw an increase in demand from some of its products because of the pandemic. Danielle Antalffy, an analyst with SVB Leerink Research, said Baxter is one of the companies the firm covers, that is relatively insulated from a negative COVID-19 impact.